Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Topazone Aerosol 40 mg Aerosol is a Health Canada–registered veterinary drug (DIN 00237639) held by Austin, Division Of Vétoquinol N.-A. Inc., containing Furazolidone. Health Canada lists its status as Cancelled Post Market (status date 03 Aug 2001). Nexara Health has matched 4 registrations of Furazolidone across 2 other regulated markets.

Health Canada registration

DIN00237639
Brand nameTopazone Aerosol
Active ingredientFurazolidone
Strength40 mg
Dosage formAerosol
RouteOphthalmic ; Topical
CompanyAustin, Division Of Vétoquinol N.-A. Inc.
StatusCancelled Post Market — 03 Aug 2001
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Furazolidone registered in other markets

4 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
TaiwanFurazolidone "Primasint"Primasint S.a.(粉)已註銷TFDA
TaiwanFurazolidone "W. Biesterfeld"W. Biesterfeld & Co.,(粉)已註銷TFDA
TaiwanFurazolidone Tablets "Ton Sheng"培力藥品工業股份有限公司錠劑已註銷TFDA
United StatesFurazolidoneDarmerica, LLCPowderFDA NDC

See every manufacturer of Furazolidone worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Topazone Aerosol (DIN 00237639) marketed in Canada?

No. Health Canada lists DIN 00237639 as Cancelled Post Market as of 03 Aug 2001.

Who holds the Canadian licence for this product?

Austin, Division Of Vétoquinol N.-A. Inc. is the company of record in the Health Canada Drug Product Database.

Is Furazolidone registered outside Canada?

Yes — Nexara Health has matched 4 registrations in 2 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00237639, status date 2001-08-03; national medicine registries: FDA NDC, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00237639, status date 2001-08-03; national medicine registries: FDA NDC, TFDA.

Health Canada Drug Product Database (DPD), DIN 00237639, status date 2001-08-03; national medicine registries: FDA NDC, TFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.